Resalis Therapeutics
ItalyEntry
2024
Hold
2yr
Status
Active
Who owns Resalis Therapeutics?
Resalis Therapeutics is currently owned by Sunstone Life Science Ventures through Sunstone Life Science Ventures V (2021 vintage), since 2024. Across its history, Resalis Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-26
Most recent investor
Sunstone Life Science VenturesSunstone Life Science Ventures V · 2021 · VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
Claris Ventures SGRActive
2021 · present(5yr) · Claris Biotech I · 2020 · Life Sciences VC
More from Sunstone Life Science Ventures V
Other portfolio companies in the same fund.
France
Netherlands
Belgium
Denmark
GermanyMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Resalis Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Resalis Therapeutics?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Resalis Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue